|
|
Other links at Articles > Rheumatology |
| 1. |
Syk Kinase Inhibitor Rapidly Reduces Disease Activity in RA
|
|
|
A new class of oral drugs for treatment of rheumatoid arthritis -- Syk kinase inhibitors -- produces a rapid reduction in disease activity, according to results of a phase II trial presented Monday at the American College of Rheumatology Annual Scientific Meeting in San Francisco. Reuters Health Information
|
| 2. |
Anti-IL-12/23 Monoclonal Antibody Useful for Psoriatic Arthritis
|
|
|
Treatment with ustekinumab, a monoclonal antibody against interleukins 12 and 23, can reduce the signs and symptoms of psoriatic arthritis and is well tolerated, according to a report in the February 12th online issue of The Lancet. Reuters Health Information
|
|
|
